ArticleCancers2020

Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma.

Kyung Ju Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.